The US Food and Drug Administration (FDA) has accepted for review Merck & Co’s New Drug Application (NDA) for ...

US late-stage oncology-focused Revolution Medicines and Iambic Therapeutics, which is developing novel medicines using its AI ...

The European Commission has approved Tevimbra (tislelizumab), alongside gemcitabine and cisplatin, for the first-line ...

US pharma major AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation today ...

BeOne Medicines - the Sino-American oncology specialist formerly known as BeiGene (SHA: 688235) - has announced that the ...

The US Food and Drug Administration (FDA) has accepted the supplemental new drug application (sNDA) for Inqovi (decitabine ...

The US Supreme Court has aided President Donald Trump in his mission to plough on with a major workforce reduction and agency overhaul impacting the US Department of Health and Human Services (HHS).

Japanese authorities are putting Eisai (TSE: 4523) under pressure to reconsider the price of its Alzheimer’s disease therapy ...

US pharma major Eli Lilly’s orforglipron is emerging as a promising oral glucagon-like peptide (GLP)-1 therapy, with upcoming clinical milestones in obesity and diabetes set to shape its market ...

French biotech Inventiva has changed up its executive team as it continues to bet on experimental MASH therapy lanifibranor, ...

The USA’s Federal Trade Commission is sending payments totaling more than $409,000 to consumers who bought products from ...

Singapore-based market expansion services provider DKSH Business Unit Healthcare announced a partnership with Germany’s Bayer ...